I’m beyond thrilled to share that I’ll be starting as an Assistant Professor in May 2023 in the department of Immunobiology
@YaleIBIO
at Yale School of Medicine
@YaleMed
! (Brief thread👇🏼)
“Drugmakers are planning a public pledge to not send any Covid-19 vaccine to the FDA for review without extensive safety and efficacy data.”
👏🏻👏🏻.
What crazy times we live in when vaccine makers are the ones keeping the regulators in check. Who would have thought.
Elated to share that my
#COVID19
paper was just REJECTED at
@cellhostmicrobe
! If you’re a young grad student or trainee, don’t take rejection too hard. This is part of the process. Dust yourself off, pick yourself up, and try again. Stay the course!
#AcademicTwitter
Some of this already announced by companies. Looks like
#Omicron
fully evades the REGN mAbs. Same with Lilly. And only one of the two AZ mAbs (just given EUA yesterday) neutralize it. Sotrovimab from Vir going strong against Omicron. Preprint linked 👇🏼
Elated to be a part of these two monkey studies studies just published in Science in collaboration with Dan Barouch. In the first study, we answered a key unanswered question: does SARS-CoV-2 immunity protect against reinfection? The answer is yes.(Thread below).
@ScienceMagazine
Two new studies in macaques offer hope that humans could develop protective immunity against
#SARSCOV2
, either as the result of a natural infection or by way of a vaccine.
@BIDMChealth
Read the research:
👉
👉
People like to rag on academia sometimes, but I would like to thank
@YaleIBIO
@YaleCII
@YaleMed
@Yale
for making me feel so welcome in my first week as
#newPI
. I look forward to interacting with grad students, postdocs, faculty and staff!
Our latest paper describing
#universal
#CoV
vaccine that can protect against
#MERSCoV
and
#SARSCoV
is now out in
#preprint
@YaleMed
Short thread 👇🏼
“Vaccine-mediated protection against merbecovirus and sarbecovirus challenge in mice”
Parents take note 👇🏼 below is Cornell’s head pediatrician getting her son vaccinated against
#COVID19
. Safe and effective
#COVID19
vaccines reduce risk of potential life-threatening
#COVID19
and long-term
#COVID
symptoms.
#VaccinesWork
Our paper characterizing a MERS-related 🦇
#CoV
is out in
@ScienceTM
! In this study we evaluated the ability of Bt-CoV 422 to replicate in primary human airway cells partially evade countermeasures. TLDR: merbecoviruses are poised for emergence (1/2)
Happy to share my pre-print describing chimeric mRNA spikes that elicit broadly neutralizing antibodies against SARS-CoV, SARS-CoV-2, and high-risk pre-emergent bat CoVs and protect against challenge in mice (thread)
@Baric_Lab
@UNCpublichealth
#COVID19
Our latest universal
#coronavirus
vaccine work is out in
@NatureComms
. We used nanoparticle vaccines that elicited broadly neutralizing antibodies in monkeys against
#SARS2
variants and protected mice against 🦇 SARS-related CoVs (Brief thread 👇🏼)
Y’all being a dad is so great. Our baby boy came on 11/11/22 and is doing great. Momma is doing great too. Excited about this new chapter!
#newdad
#academicpoppa
Guys I have the best lab mates! Check out these onesies. We have a super creative and crafty member (Rachel Graham) who made these, and this super cool card. At week 39, my partner and I are anxiously waiting for our baby’s arrival!
@UNCpublichealth
@Baric_Lab
Our study with Dan Barouch is out in
@NEJM
. We compared the kinetics and durability of the Moderna, Pfizer, and JnJ
#COVID19
vaccines. JnJ had lower early peak antibody compared to Pfizer and Moderna but were very stable to 8 months post vax.
Unsurprising yet reassuring. T cell immunity remains stable against more divergent variants like
#OmicronVirus
. While there’s a small decrease in T cell recognition of
#Omicron
, this is really great news.
Our
#pangolin
#CoV
characterization paper is finally out in Nature Microbiology. In this study, we characterized the tropism, immunogenicity, and pathogenesis of a SARS2-related CoV sequenced from a pangolin. Glad
@aschaefe29
and I contributed.
@Baric_Lab
New data alert 🚨 Worried about the
#SARSCoV2
variants like the South African B.1.351 ? Good news is that the
#CoV
vaccine like the one from
#Moderna
and
#Pfizer
can protect against the B.1.351 variant in aged (highly vulnerable) mice. And so can our universal
#mRNA
vaccines!
We have added more LIVE VIRUS UK B117 and mink neutralization variant data, in addition to SA B1.351 VOC, comparing our universal CoV mRNA vaccine strategy to the SARS-CoV-2 mRNA vax. All three variants are efficiently neutralized despite a small reduction against the SA B1.351.
We conclude that the epitope bound by DH1047 is an Achilles Heel of sarbecoviruses and could be a template for a universal vaccine. Our antibody, DH1047, could not only be deployed in the current
#COVID19
pandemic but could also be stockpiled to prevent a SARS-CoV-3 epidemic.
Extremely humbled to have made it onto this list with other
#Latinx
scientists that are my own role models. Thank you to my peers for this totally unexpected surprise. I look forward to inspire the next generation of scientists from diverse backgrounds.
#LatinxHeritageMonth
I am hiring postdocs! Come join our lab
@YaleIBIO
and
@YaleCII
and
@YaleMed
!
I’m also hiring an Associate Research Scientist and a Lab Manager! If you know great and enthusiastic lab peeps, please send them my way!
Please RT
Elated to share our
#COVID19
vaccine paper just published in
@nature
: a single shot Ad26 protects against
#SARSCoV2
infection in rhesus macaques. This vaccine is going into human Phase 3 clinical trials (Thread)
@Baric_Lab
@BWFUND
A 2nd report today from
@ljiresearch
also demonstrates vaccination induced T-cells vs Omicron (B.1.1,519) well preserved compared with all variants and with 3 different vaccines
@aetarke
@SetteLab
This is alarming. Dr. Fauci thinks the US is failing at this. Unlike other countries where anyone who suspects a
#COVID19
infection can be quickly tested, in the US only your physician can order a test for you. Ccing
@SalliePermar
@Jmsteinbrink
@CarlosdelRio7
@AJMarkm
Dr. Fauci on availability of coronavirus tests in the US:
“The system is not really geared to what we need right now, what you are asking for. That is a failing … Let’s admit it.”
I’m excited to share my first-author paper just published in
@CellReports
. In this study, we identify a unique role for the genetic variation observed in
#Dengue
#virus
serotype 2 among the various circulating genotypes. (1/3)
@UNCpublichealth
@BWFUND
Congratulations to the recipients of the
@fredhutch
2022 Dr. Eddie Méndez award! 👏
The recipients are postdoctoral researchers from across the US with research expertise in
#cancer
,
#InfectiousDisease
, and basic sciences.
Learn more:
I am hiring a lab manager. Come join the Laboratory of Viral Pathobiology and Immunity!
@YaleIBIO
We are a fun, supportive, and friendly group.
We welcome all and actively work to foster a lab environment where everyone feels welcome.
Please RT
Glad to see this pre-print out with Bart Haynes and Kevin Saunders. Here,
@Dapeng_LI
,
@aschaefe29
, others, and I, show that in vitro antibody dependent enhancement (ADE) of SARS-CoV-2 antibodies do not mediate ADE in in vivo both in mice and in monkeys.
@TheDHVI
@Baric_Lab
Despite all of the stressful
#COVID19
work in the lab, I recently received great news. My NIAID
#F32
scored in the 1 percentile. Now praying to the “grant gods” for a payline above a 14 😂. Thanks to my mentors for your continued support - you know who you are.
#AcademicChatter
Guys I have the best lab mates! Check out these onesies. We have a super creative and crafty member (Rachel Graham) who made these, and this super cool card. At week 39, my partner and I are anxiously waiting for our baby’s arrival!
@UNCpublichealth
@Baric_Lab
Ecstatic to share my
#COVID19
co-first author paper just out in Cell! This study was co-led by
@Y_Jacob_Hou
, Kenichi,
@caitelizedwards
, and I. This paper would not have been possible without many others from the
@Baric_Lab
and from
@UNC
(Thread below)
Guys this is my bay mate Jacob. He’s a postdoc in the
@Baric_Lab
. He’s one of our in-house molecular virology extraordinaries and a prime mover of the all of the reagents being generated to study
#SARS2
in the BSL3. Welcome to Twitter Jacob.
Congrats to my beautiful and brilliant wife Kelsey on a phenomenal PhD dissertation defense! She killed it! Meet the # toxicologist Dr. Kelsey A. Behrens, Ph.D.
#luckyguy
#proudhusband
#Phdone
#phdchat
Intro to my new followers. I’m a scientist. I study
#dengue
and
#SARSCoV2
viruses. My research aims to understand how these viruses evade antibodies. The goal of my research is to inform how to best design effective vaccines against these pandemic viruses.
#COVID
Most evenings during the last (almost) two years as a
#COVID19
vaccine and antivirals researcher, I’ve done computer work/email to keep up the pace. This evening I’m just too tired for it. I’ll be watching
@netflix
and going to bed early ✌🏻.
#Omicron
and BSL3 work has me tired.
@TamayoLab
The same was said to me during grad school at Duke. How did I deal with the situation? I outperformed every single one of these voices from so-called “friends” by all measures (i.e., # of first author papers etc). And I recently received a perfect score on a non-diversity F32.
#newPI
wins. 1) Getting our lab space to pass inspection with the CT Department of Public Health, 2) getting our infectious agent registration
#EHS
approved, 3) getting our rDNA registration
#EHS
approved, and 4) two talented postdocs starting tomorrow 😄 🙌🏼
#IYKYK
Animals that received the full length
#SARS_CoV_2
Spike had >3 logs reduction in respiratory tissues. Vaccine-elicited neutralizing antibodies correlated with protective efficacy. These findings are encouraging for the development of
#Covid_19
vaccine.
The
#COVID19
vaccines are working the way they were intended.
I and others spoke with the brilliant
@KatherineJWu
about sterilizing immunity or lack thereof.
COVID-19 Vaccines: The Myth of 'Sterilizing Immunity'
@TheAtlantic
Stay in your lane,
@elonmusk
. We’ll leave the electric cars and rockets to you. Leave the virology/Immunology/epidemiology to us experts, meaning biomedical scientists and medical doctors. Thank you. Tweets like these are irresponsible.
@FxzzOnTheBeat
Virality of C19 is overstated due to conflating diagnosis date with contraction date & over-extrapolating exponential growth, which is never what happens in reality. Keep extrapolating & virus will exceed mass of known universe!
The protective immunity in monkeys was mediated by anamestic responses, suggesting that protection is mediated by immunologic control. In the second study, we vaccinated 35 rhesus monkeys with different forms of the
#SARS
spike
#vaccine
.
Any others out there who worked non-stop on
#COVID19
for the last 1.5 years still feel exhausted/burned out despite taking time off?
#askingforme
burnout is real. It’s probably worse for the physicians who have worked arduous shifts and no end in sight now with the
#Delta
surge.
The
#lab
’s first lunch outing to welcome new members. We had New Haven style
#apizza
from Sallie’s. Stay tuned for upcoming science updates from this highly talented set of
#womeninscience
trainees!
@YaleIBIO
Two injections of an mRNA-based
#SARSCoV2
vaccine elicited high levels of NAb and Th1 CD4 T-cell responses in rhesus macaques. Two days after challenge with intranasal and intratracheal virus, viral replication was undetectable in BAL fluid and nasal secretions.
#COVID19
I received the packages containing the NHP
#SARS2
vaccinated samples tweeps.
#BSL3
fun? ... yeah maybe in retrospect it will seem fun. 😅 wish me luck!
@Baric_Lab
@UNCpublichealth
Out of office email notifications turned on ✅ . Going on vacation to Key West, FL. Will be enjoying the sun, the pool, and the beach. Will not, for the first time in a long time, be thinking about lab or pending work ✌🏻
#WorkLifeBalance
Highlight of my week: sending our industry partner the live-virus neutralization data of their potent neutralizing monoclonal antibodies. And I sent them my protocol for their FDA application that’s going in! 🙌🏼
#antibodies
#therapeutics
now back to the
#BSL3
today!
Science can be hard. Peer review can be a demoralizing process when the work that you pour your heart and soul into is criticized and torn apart.
I like to remember small and big victories. This one is the result of a fun collaboration and teamwork.
#AcademicTwitter
@ScienceTM
Enjoying the first couple of days off since the
#COVID19
pandemic began. I’m feeling a bit guilty not being in lab, but we have been pushing hard for key data required to advance the two leading vaccines for Phase III trials. I’ll try not to feel guilty and enjoy the beach😎
Glad to be a part of this study just out in
@nature
with the Crowe, Diamond, Baric, and Barouch labs. Massive team effort for the identification of extremely potent
#SARSCoV2
mAbs. These mAbs have the potential to be used as therapeutics for
#COVID
-19
Beaming with pride to finally be a target for trolls and anti-vaxx phony
@Twitter
accounts. I guess that must mean my advocacy for
#COVID19
vaccines is working. I’ll wear this one as a badge of honor.
#VaccinesWork
Our latest universal vaccine study with
@BarouchLab
is out in
@Nature_NPJ
Vaccines.
We targeted the most conserved sarbecovirus proteins: the RNA-dependent RNA polymerase and the Helicase.
@aschaefe29
@Baric_Lab
📢 Please RT - incredible opportunity for 8 years of funding from postdoc>TT faculty position in the biomedical sciences
@HHMINEWS
#HannaGrayFellows
program
#DEI
Deadline is 12/7/2022
Thanks for the swag
@HHMINEWS
! I’m thankful for the opportunity to present my work at the HG symposium. Best of luck to all! I look forward to meeting the rest of the participants via Zoom.
Thrilled to share my final first-author publication in
@mbiojournal
from my PhD in
@SalliePermar
lab. In this study, we isolated 225 HIV-specific monoclonal
#antibodies
from HIV-infected nontransmitting and transmitting women.(Thread - 1/n)
Our
#AViDD
has a new paper out. We characterized an oral drug 💊 with broad in vivo efficacy against all tested coronaviruses🦠 “Efficacy of the oral nucleoside prodrug GS-5245 (Obeldesivir) against SARS-CoV-2 and coronaviruses with pandemic potential”
Had a great morning session in the
#BSL3
today! Many potent neutralizing monoclonal antibodies in the pipeline for therapeutics. Despite all of the doom and gloom in the news, these data makes me optimistic for
#COVID19
treatments! These data make think that the future is bright.
I am highly enthusiastic about continuing to explore broadly acting countermeasures against large groups of viruses to prevent pandemics before they happen! Stay tuned for more coming from our group on the antivirals front in this area!
@UNCpublichealth
Looking forward giving a talk on Immunologic Approached to Emerging Coronaviruses and Flaviviruses at the
@GlobalVirusNews
hosted today by
@JohnsHopkinsSPH
.
Bonus: listening to my “scientific grandmother” Diane Griffin present her expert view on measles virus pathogenesis.
Spoke today with remarkable scientist
@KizzyPhD
about her pivotal role in the development of the
#COVID19
#mRNA
vaccines & common vaccine questions. I loved her "alarm clock" analogy of why mRNA vaccines require 2 doses. Watch our full conversation here:
The hypocrisy of this tweet is beyond me. Here’s someone who trained in a “majoritarian” PI’s lab at an elite institution. Yet when URMs do the same then something is wrong? And suddenly their accomplishments are solely because of the clout of their postdoc PI? I don’t think so.
Congrats to our fearless
@Baric_Lab
leader, Ralph Baric, on getting elected into the American Academy of Arts and Sciences!
And in the same week as getting inducted into the National Academy of Sciences!
@UNCpublichealth